These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. An overview of clinical cancer chemoprevention studies with emphasis on positive phase III studies. Alberts DS; Garcia DJ J Nutr; 1995 Mar; 125(3 Suppl):692S-697S. PubMed ID: 7884553 [TBL] [Abstract][Full Text] [Related]
24. Chemoprevention trials in the cervix: design, feasibility, and recruitment. Mitchell MF; Hittelman WN; Lotan R; Nishioka K; Tortolero-Luna G; Richards-Kortum R; Hong WK J Cell Biochem Suppl; 1995; 23():104-12. PubMed ID: 8747384 [TBL] [Abstract][Full Text] [Related]
25. Evaluation of human trial findings. Huttunen JK IARC Sci Publ; 1996; (139):271-6. PubMed ID: 8923037 [TBL] [Abstract][Full Text] [Related]
26. Statistical design and monitoring of the Carotene and Retinol Efficacy Trial (CARET). Thornquist MD; Omenn GS; Goodman GE; Grizzle JE; Rosenstock L; Barnhart S; Anderson GL; Hammar S; Balmes J; Cherniack M Control Clin Trials; 1993 Aug; 14(4):308-24. PubMed ID: 8365195 [TBL] [Abstract][Full Text] [Related]
27. Is There a Future for Chemoprevention of Prostate Cancer? Bosland MC Cancer Prev Res (Phila); 2016 Aug; 9(8):642-7. PubMed ID: 27099271 [TBL] [Abstract][Full Text] [Related]
28. Chemoprevention of oral leukoplakia with vitamin A and beta carotene: an assessment. Sankaranarayanan R; Mathew B; Varghese C; Sudhakaran PR; Menon V; Jayadeep A; Nair MK; Mathews C; Mahalingam TR; Balaram P; Nair PP Oral Oncol; 1997 Jul; 33(4):231-6. PubMed ID: 9307711 [TBL] [Abstract][Full Text] [Related]
29. Stopping the active intervention: CARET. Bowen DJ; Thornquist M; Anderson K; Barnett M; Powell C; Goodman G; Omenn G; Control Clin Trials; 2003 Feb; 24(1):39-50. PubMed ID: 12559641 [TBL] [Abstract][Full Text] [Related]
30. Development of difluoromethylornithine (DFMO) as a chemoprevention agent. Meyskens FL; Gerner EW Clin Cancer Res; 1999 May; 5(5):945-51. PubMed ID: 10353725 [TBL] [Abstract][Full Text] [Related]
33. Vitamin A and cancer prevention II: comparison of the effects of retinol and beta-carotene. de Klerk NH; Musk AW; Ambrosini GL; Eccles JL; Hansen J; Olsen N; Watts VL; Lund HG; Pang SC; Beilby J; Hobbs MS Int J Cancer; 1998 Jan; 75(3):362-7. PubMed ID: 9455794 [TBL] [Abstract][Full Text] [Related]
34. The role of chemoprevention in cancer control. Greenwald P; Kelloff GJ IARC Sci Publ; 1996; (139):13-22. PubMed ID: 8923016 [TBL] [Abstract][Full Text] [Related]
35. Surrogate endpoint biomarkers for phase II cancer chemoprevention trials. Kelloff GJ; Boone CW; Crowell JA; Steele VE; Lubet R; Doody LA J Cell Biochem Suppl; 1994; 19():1-9. PubMed ID: 7823579 [TBL] [Abstract][Full Text] [Related]
37. Chemoprevention research in Europe. Hakama M Int J Cancer; 1997; Suppl 10():30-3. PubMed ID: 9209017 [TBL] [Abstract][Full Text] [Related]
38. Patient participation and compliance in cancer chemoprevention trials: issues and concerns. Tangrea JA Proc Soc Exp Biol Med; 1997 Nov; 216(2):260-5. PubMed ID: 9349695 [TBL] [Abstract][Full Text] [Related]
39. The Carotene and Retinol Efficacy Trial (CARET) to prevent lung cancer in high-risk populations: pilot study with cigarette smokers. Goodman GE; Omenn GS; Thornquist MD; Lund B; Metch B; Gylys-Colwell I Cancer Epidemiol Biomarkers Prev; 1993; 2(4):389-96. PubMed ID: 8348063 [TBL] [Abstract][Full Text] [Related]
40. Surrogate end-point biomarker analysis in a retinol chemoprevention trial in current and former smokers with bronchial dysplasia. Lam S; Xu X; Parker-Klein H; Le Riche JC; Macaulay C; Guillaud M; Coldman A; Gazdar A; Lotan R Int J Oncol; 2003 Dec; 23(6):1607-13. PubMed ID: 14612933 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]